Venetoclax-based quadruplet therapy with trametinib for patients with RAS-mutated AML and MDS
Andrius Žučenka • 11 Dec 2022
Update on venetoclax combination trials for elderly AML from ASH 2017
Marina Konopleva • 9 Dec 2017
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.